These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17077554)

  • 1. Synthesis and anti-tumor activity of a fluorinated analog of medroxyprogesterone acetate (MPA), 9alpha-fluoromedroxyprogesterone acetate (FMPA).
    Murata N; Fujimori S; Ichihara Y; Sato Y; Yamaji T; Tsuboi H; Uchida M; Suzuki H; Yamada M; Oikawa T; Nemoto H; Nobuhiro J; Choshi T; Hibino S
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1567-70. PubMed ID: 17077554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
    Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic activity of a novel synthetic agent, 9alpha-fluoromedroxyprogesterone acetate.
    Yamaji T; Tsuboi H; Murata N; Uchida M; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 1999 Oct; 145(1-2):107-14. PubMed ID: 10530777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of 9alpha-fluoromedroxyprogesterone acetate in rats: comparison with medroxyprogesterone acetate.
    Kozutsumi D; Kawashima A; Sugimoto T; Kotohda Y; Fujimori S; Takami M; Kohno T; Oikawa T; Sugino E; Choshi T; Hibino S
    Biopharm Drug Dispos; 1999 Sep; 20(6):277-84. PubMed ID: 10701698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of laser-induced choroidal neovascularization by subconjunctival injection of 9alpha-fluoromedroxyprogesterone acetate (FMPA), an anti-angiogenic agent, in rats.
    Murata N; Yamaji T; Uchida M; Tsuboi H; Suzuki H; Yamada M; Oikawa T; Nobuhiro J; Choshi T; Hibino S
    Biol Pharm Bull; 2006 Dec; 29(12):2410-4. PubMed ID: 17142973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a new potent anti-angiogenic agent, 17 alpha-acetoxy-9 alpha-fluoro-6 alpha-methylprogesterone (9 alpha-fluoromedroxyprogesterone acetate [FMPA]).
    Sugino E; Fujimori S; Hibino S; Choshi T; Ichihara Y; Sato Y; Yamaji T; Tsuboi H; Murata N; Uchida M; Shimamura M; Oikawa T
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):421-3. PubMed ID: 9118456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H; Iino Y; Izuo M; Takikawa H
    Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
    Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
    Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S; Spinola PG; Labrie F
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity.
    Spreafico F; Filippeschi S; Malfiore C; Noseda S; Falautano P; Serraglia N
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):45-51. PubMed ID: 6211360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
    Labrie F; Li S; Bélanger A; Côté J; Mérand Y; Lepage M
    Breast Cancer Res Treat; 1993; 26(3):253-65. PubMed ID: 8251650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a combined administration of 5-fluorouracil and medroxyprogesterone acetate on pyrimidine nucleoside phosphorylases and thymidylate synthetase in 7,12-dimethylbenz.
    Nagasawa M; Iino Y; Koibuchi Y; Andoh T; Morishita Y
    Oncol Rep; 2001; 8(3):543-6. PubMed ID: 11295077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
    Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sakamoto S; Hara Y; Mitamura T; Sassa S; Kudo H; Suzuki S; Kuwa K; Okayasu I; Shinoda H
    Anticancer Drugs; 1998 Apr; 9(4):351-7. PubMed ID: 9635926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate.
    Li S; Lepage M; Mérand Y; Bélanger A; Labrie F
    Breast Cancer Res Treat; 1992; 24(2):127-37. PubMed ID: 8443400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
    Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
    Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.